Tasigna (nilotinib) in chronic myeloid leukemia treatment-free remission after nearly 2 years: an interview with Adam Mead

Future Oncology, Ahead of Print.


from Cancer via ola Kala on Inoreader http://ift.tt/2zzCeSP
via IFTTT